| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 103.075 | 76 |
| GSM780708 | Untreated after 4 days (C2_1) | 92.4224 | 74 |
| GSM780709 | Untreated after 4 days (C3_1) | 111.595 | 77 |
| GSM780719 | Untreated after 4 days (C1_2) | 106.774 | 76 |
| GSM780720 | Untreated after 4 days (C2_2) | 95.93 | 75 |
| GSM780721 | Untreated after 4 days (C3_2) | 100.78 | 75 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 79.9599 | 72 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 100.218 | 75 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 78.3164 | 71 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 80.0139 | 72 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 110.714 | 77 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 87.1972 | 73 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 108.85 | 76 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 93.4092 | 74 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 106.829 | 76 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 131.854 | 79 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 93.8274 | 74 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 116.631 | 77 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 95.9787 | 75 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 93.1005 | 74 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 79.1979 | 71 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 93.0424 | 74 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 97.1108 | 75 |